Related Experiment Video

Updated: Jul 7, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Predictors of prognosis in patients with peripartum cardiomyopathy

Nilüfer Duran1, Haci Günes, Ibrahim Duran

  • 1Cardiology Department, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. eksduran@yahoo.com

International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|February 19, 2008
PubMed

Insights

Peripartum cardiomyopathy outcomes vary, with some patients recovering fully and others experiencing persistent dysfunction or death. Echocardiographic measurements like left ventricular ejection fraction and end-systolic diameter can predict recovery.

Area of Science:

  • Cardiology
  • Maternal Health
  • Echocardiography

Background:

  • Peripartum cardiomyopathy (PPCM) is a rare form of heart failure affecting women during late pregnancy or early postpartum.
  • Long-term outcomes and prognostic factors for PPCM remain an area of active research.

Purpose of the Study:

  • To evaluate the long-term follow-up results of patients diagnosed with peripartum cardiomyopathy.
  • To identify echocardiographic findings at diagnosis that correlate with prognosis.

Main Methods:

  • Retrospective analysis of 33 patients hospitalized with PPCM between 1995 and 2007.
  • Collection and evaluation of initial echocardiographic data and long-term clinical status.

Main Results:

  • Complete recovery was observed in 24% of patients, while 30% died, 6% underwent heart transplantation, and 39% had persistent left ventricular dysfunction.
  • Initial left ventricular end-systolic diameter <= 5.5 cm and left ventricular ejection fraction > 27% were associated with complete recovery.

Conclusions:

  • Specific echocardiographic parameters at diagnosis may predict the likelihood of left ventricular function recovery in PPCM patients.
  • Left ventricular ejection fraction > 27% and end-systolic diameter < or = 5.5 cm are potential indicators for favorable prognosis in PPCM.
Abstract

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...